Blogir-3 syrup 5mg/ml 60ml

Blogir-3 syrup instruction

You can buy Blogir-3 syrup here

Indications

Allergic rhinitis (elimination or relief of sneezing, nasal congestion, discharge of mucus from the nose, itching of the nose, itching of the palate, itching and redness of the eyes, tearing);
- urticaria (reduction or elimination of pruritus, rash).

Contraindications

Hypersensitivity to the drug;
- pregnancy and lactation;
- age up to 1 year;
- hereditary disorders of fructose tolerance (due to the presence of sorbitol in the composition of Blogir-3 syrup).

Carefully

In the presence of severe renal failure, Blogir-3 syrup should be taken with caution.

Pregnancy and lactation

Use of the drug BLOGIR-3 syrup during pregnancy is contraindicated due to the lack of clinical data on the safety of its use in this period.
Desloratadine is excreted in breast milk, so the use of the drug during breastfeeding is contraindicated.

Composition

Active ingredient: desloratadine.
Product form: Syrup 5 mg / ml 60ml.

Mode of application

Inside, regardless of the meal, washed down with a small amount of water.
Children aged 1 to 5 years: 1.25 mg (2.5 ml syrup) 1 time per day;
children aged 6 to 11 years: 2.5 mg (5 ml of syrup) 1 time per day;
adults and teenagers from 12 years: 5 mg (10 ml of syrup) 1 time per day.
In case of seasonal (intermittent) allergic rhinitis (if symptoms persist for less than 4 days per week or less than 4 weeks per year), the course of the disease should be assessed. With the disappearance of symptoms, Blogir-3 syrup should be stopped, with the reappearance of symptoms, the drug should be resumed. For year-round (persistent) allergic rhinitis (if symptoms persist for more than 4 days a week or more than 4 weeks a year), the drug should be taken during the entire period of allergen exposure.

special instructions

Interactions: Interactions with repeated combined use of desloratadine with ketoconazole, erythromycin, azithromycin, fluoxetine and cimetidine, clinically significant changes in the concentration of desloratadine in plasma was not detected.
Blogir-3 syrup does not enhance the effect of alcohol on the central nervous system.
Eating does not affect the effectiveness of Blogir-3 syrup.

Side effects

During clinical studies in children under the age of 2, the following adverse effects were observed with the use of the drug, the frequency of which was slightly higher than with placebo: diarrhea, fever, insomnia; in children aged 2 to 11 years, the incidence of side effects was the same as with placebo; in adults and adolescents from 12 years of age when using Blogir-3 syrup, the following adverse events were noted, the frequency of which was slightly higher than when using a placebo: increased fatigue, dry mouth, headache.
The following side effects were very rare:
From the side of the central nervous system: hallucinations, dizziness, drowsiness, insomnia, psychomotor hyperactivity, convulsions.
Since the cardiovascular system: tachycardia, palpitations.
On the part of the digestive system: abdominal pain, nausea, vomiting, dyspepsia, diarrhea.
On the part of the liver and biliary tract: increased activity of liver enzymes, bilirubin content, hepatitis.
From the musculoskeletal system: myalgia.
Allergic reactions: anaphylaxis, angioedema, dyspnea, pruritus, rash, including urticaria, photosensitization.
If any of the side effects indicated in the instruction are aggravated, or you have noticed any other side effects that are not indicated in the instruction, inform your doctor.

Use in pediatrics

The efficacy and safety of the use of the drug BLOGIR-3 syrup in children under the age of 1 year has not been established.
In most cases, rhinitis in children under 2 years of age has an infectious nature. Studies on the effectiveness of desloratadine in rhinitis infectious etiology has not been conducted.
The differential diagnosis between allergic rhinitis and rhinitis of other origin in children under 2 years of age presents certain difficulties. When conducting a differential diagnosis should pay attention to the presence or absence of foci of infection or structural abnormalities of the upper respiratory tract, to conduct a thorough history, examination, as well as appropriate laboratory tests and skin tests.

Impact on the ability to drive trans. Wed and fur .

In the recommended dose, Blogir-3 syrup does not affect the ability to drive vehicles or mechanisms. However, in very rare cases, some patients may experience drowsiness while taking desloratadine, which may affect their ability to drive or work with machinery.

Storage conditions

Store at a temperature not higher than 25 ° С.

Terms of sell

You don't need a prescription to buy Blogir-3 syrup.